Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agios Pharmaceuticals (AGIO) Net Income: 2011-2024

Historic Net Income for Agios Pharmaceuticals (AGIO) over the last 14 years, with Dec 2024 value amounting to $673.7 million.

  • Agios Pharmaceuticals' Net Income fell 110.91% to -$103.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$403.0 million, marking a year-over-year decrease of 160.06%. This contributed to the annual value of $673.7 million for FY2024, which is 291.35% up from last year.
  • As of FY2024, Agios Pharmaceuticals' Net Income stood at $673.7 million, which was up 291.35% from -$352.1 million recorded in FY2023.
  • Over the past 5 years, Agios Pharmaceuticals' Net Income peaked at $2.0 billion during FY2021, and registered a low of -$352.1 million during FY2023.
  • Its 3-year average for Net Income is $29.9 million, with a median of -$231.8 million in 2022.
  • Its Net Income has fluctuated over the past 5 years, first surged by 101,255.30% in 2021, then slumped by 111.82% in 2022.
  • Yearly analysis of 5 years shows Agios Pharmaceuticals' Net Income stood at $1.9 million in 2020, then surged by 101,255.30% to $2.0 billion in 2021, then plummeted by 111.82% to -$231.8 million in 2022, then crashed by 51.89% to -$352.1 million in 2023, then surged by 291.35% to $673.7 million in 2024.